Amyris unveils clinical clean skincare brand Terasana to address dry skin and inflammation
23 Aug 2021 --- Synthetic biotechnology company Amyris has launched Terasana Clinical, a clean skincare brand.
This is the first of three expected product launches, which Amyris has announced will happen this summer.
Terasana Clinical’s debut skincare product, Clear + Control Healthy Skin Serum, seeks to tackle dry skin, skin flaking, irritation and redness with its moisturizing and anti-inflammatory properties, which are designed to clear and balance the skin’s appearance.
The pure and powerful Terasana Clinical Clear + Control Skin Serum is formulated without parabens, phthalates, synthetic fragrances and mineral oils, and is non-toxic, vegan, cruelty-free and ethically sourced.
Its planet-friendly brand also uses packaging made from 100 percent recycled material and recyclable glass bottles.
Using patented ingredients
Clear + Control Healthy Skin Serum is a patented formulation that combines two of Amyris’ sustainably sourced ingredients, Squalane and Cannabigerol (CBG).
Squalane is Amyris’ high-performance moisturizer that has demonstrated skin therapy benefits in clinical and consumer studies.
Amyris’ CBG is an anti-inflammatory and anti-microbial non-psychoactive (contains no THC) minor cannabinoid.It contributes to skin health by improving the skin’s microbiome and enabling the penetration of cannabinoids and other skincare actives to enhance product performance.
Amyris’ CBG is an anti-inflammatory and anti-microbial non-psychoactive (contains no THC) minor cannabinoid. Both Squalane and CBG are developed through Amyris’ proprietary Lab-to-Market science and technology process.
“CBG has a variety of proven skin benefits and through our well-established fermentation technology, we are able to manufacture CBG at scale and at a much lower cost than existing alternatives,” says John Melo, president and CEO of Amyris.
“We believe that clean CBG has opened up new avenues in sustainable and effective skincare and that it has the potential to be a breakthrough in addressing the acne market. We are on track to launch three new clean beauty consumer brands this month, which is a testament to the consistent performance and execution by our team.”
“We continue to build on our current sales growth momentum in the third quarter and expect the new brands and consumer activity to contribute significant new revenue during the second half of this year.”
Tackling inflammation
A clinical study conducted with Clear + Control Healthy Skin Serum demonstrated a 92 percent reduction of blemishes after four weeks with results based on self-assessments by participants with dry skin, skin flaking, irritation and redness.
The study demonstrated that the anti-inflammatory and anti-microbial properties of CBG combined with Squalane improves and nourishes the skin by balancing the skin’s microbiome.
Compared to other products that address acne and other common skincare issues, the Terasana Clinical formulation reduces inflammation more quickly and more effectively, the company supports.
Dr. Mamina Turegano, triple-board certified Dermatologist and Terasana Clinical brand ambassador comments: Terasana Clinical is the only skincare brand I know of that combines highly effective, proven ingredients to clear blemishes and breakouts quickly while also nourishing the skin at the same time.
“The technology used to develop this product provides consumers a chance to experience clear skin with reduced concern for irritation or dryness.”
Amyris had a very active year, evident in its full-year financial results for 2020. The company reported strong growth and expanding profit margins, driven by six ingredient launches and multiple partnerships and investments.
In March, DSM acquired the flavor and fragrance bio-based intermediates business of Amyris for an upfront consideration of US$150 million. The deal added seven intermediate products to DSM’s existing personal care and aroma ingredient activities, extending its offerings in bio-based ingredients for the F&F and cosmetics industries.
By Kristiana Lalou
